Monika Schoels

Summary

Country: Austria

Publications

  1. ncbi Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis
    Monika Schoels
    2nd Department of Internal Medicine, Hietzing Hospital, Vienna, Austria
    Ann Rheum Dis 71:1303-8. 2012
  2. ncbi Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
    Monika Schoels
    2nd Department of Internal Medicine, Hietzing Hospital, Wolkersbergenstrasse 1, 1130 Vienna, Austria
    Ann Rheum Dis 69:995-1003. 2010
  3. ncbi Treating rheumatoid arthritis to target: recommendations of an international task force
    Josef S Smolen
    Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Waehringer Guertel 18 20, Vienna, Austria
    Ann Rheum Dis 69:631-7. 2010
  4. ncbi Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
    Monika Schoels
    Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18 20, Vienna, Austria
    Ann Rheum Dis 69:638-43. 2010
  5. ncbi Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis
    Monika Schoels
    Second Department of Medicine, Hietzing Hospital, Vienna, Austria
    Ann Rheum Dis 69:1441-7. 2010
  6. ncbi Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008
    Monika Schoels
    2nd Department of Medicine, Centre for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria
    Ann Rheum Dis 69:575-8. 2010
  7. ncbi Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review
    Monika Schoels
    2nd Department of Internal Medicine, Hietzing Hospital, Vienna, Austria
    J Rheumatol Suppl 87:20-5. 2011

Detail Information

Publications7

  1. ncbi Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis
    Monika Schoels
    2nd Department of Internal Medicine, Hietzing Hospital, Vienna, Austria
    Ann Rheum Dis 71:1303-8. 2012
    ..Optimal treatment for rheumatoid arthritis (RA) after inadequate response (IR) to tumour necrosis factor α inhibitors (TNFi) remains uncertain...
  2. ncbi Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
    Monika Schoels
    2nd Department of Internal Medicine, Hietzing Hospital, Wolkersbergenstrasse 1, 1130 Vienna, Austria
    Ann Rheum Dis 69:995-1003. 2010
    ..To review the cost effectiveness of rheumatoid arthritis (RA) treatments and inform the clinical recommendations by the European League Against Rheumatism...
  3. ncbi Treating rheumatoid arthritis to target: recommendations of an international task force
    Josef S Smolen
    Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Waehringer Guertel 18 20, Vienna, Austria
    Ann Rheum Dis 69:631-7. 2010
    ..Aiming at therapeutic targets has reduced the risk of organ failure in many diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid arthritis (RA)...
  4. ncbi Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
    Monika Schoels
    Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18 20, Vienna, Austria
    Ann Rheum Dis 69:638-43. 2010
    ..To summarise existing evidence on a target oriented approach for rheumatoid arthritis (RA) treatment...
  5. ncbi Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis
    Monika Schoels
    Second Department of Medicine, Hietzing Hospital, Vienna, Austria
    Ann Rheum Dis 69:1441-7. 2010
    ..Therefore, the reliability and validity of DAREA (for 'Disease Activity index for REactive Arthritis'), which was originally developed for reactive arthritis and employs a 66/68 joint count, was tested in patients with PsA...
  6. ncbi Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008
    Monika Schoels
    2nd Department of Medicine, Centre for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria
    Ann Rheum Dis 69:575-8. 2010
    ..The importance of tight control and early treatment, rapidly altered if goals are not achieved, is supported by evidence. However, it is unknown to what extent these insights are accepted by practitioners in clinical practice...
  7. ncbi Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review
    Monika Schoels
    2nd Department of Internal Medicine, Hietzing Hospital, Vienna, Austria
    J Rheumatol Suppl 87:20-5. 2011
    ..We reviewed published evidence on the diagnostic and prognostic performance of autoantibodies and soluble biomarkers in UPIA...